loadpatents
Patent applications and USPTO patent grants for Shi; Yi-Qun.The latest application filed is for "melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy".
Patent | Date |
---|---|
Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy Grant 11,286,280 - Yang , et al. March 29, 2 | 2022-03-29 |
Melanocortin-1 Receptor-Specific Peptides for Cytokine Storm and Inflammation Therapy App 20200339631 - Yang; Wei ;   et al. | 2020-10-29 |
Melanocortin receptor-specific peptide with C-terminal naphthylalanine Grant 10,711,039 - Yang , et al. | 2020-07-14 |
Melanocortin receptor-specific peptides Grant 10,632,171 - Shi , et al. | 2020-04-28 |
Melanocortin Receptor-Specific Peptides App 20190216887 - Shi; Yi-qun ;   et al. | 2019-07-18 |
Melanocortin receptor-specific peptides Grant 10,179,804 - Shi , et al. Ja | 2019-01-15 |
Melanocortin-1 receptor-specific linear peptides Grant 10,106,578 - Yang , et al. October 23, 2 | 2018-10-23 |
Melanocortin-1 receptor-specific cyclic hexapeptides Grant 10,017,539 - Yang , et al. July 10, 2 | 2018-07-10 |
Melanocortin Receptor-Specific Peptide with C-Terminal Naphthylalanine App 20180148478 - Yang; Wei ;   et al. | 2018-05-31 |
Melanocortin-1 Receptor-Specific Linear Peptides App 20170145056 - Yang; Wei ;   et al. | 2017-05-25 |
Melanocortin-1 receptor-specific linear peptides Grant 9,580,466 - Yang , et al. February 28, 2 | 2017-02-28 |
Melanocortin-1 Receptor-Specific Cyclic Hexapeptides App 20170008931 - Yang; Wei ;   et al. | 2017-01-12 |
Melanocortin Receptor-Specific Peptides App 20160318977 - Shi; Yi-qun ;   et al. | 2016-11-03 |
Melanocortin receptor-specific heptapeptides Grant 9,458,201 - Shi , et al. October 4, 2 | 2016-10-04 |
Melanocortin-1 receptor-specific cyclic peptides Grant 9,447,148 - Yang , et al. September 20, 2 | 2016-09-20 |
Melanocortin Receptor-Specific Peptides App 20150252077 - Dodd; John H. ;   et al. | 2015-09-10 |
Melanocortin receptor-specific peptides Grant 9,040,663 - Dodd , et al. May 26, 2 | 2015-05-26 |
Melanocortin-1 Receptor-Specific Linear Peptides App 20150119341 - Yang; Wei ;   et al. | 2015-04-30 |
Melanocortin-1 Receptor-Specific Cyclic Peptides App 20150038434 - Yang; Wei ;   et al. | 2015-02-05 |
Melanocortin-1 receptor-specific linear peptides Grant 8,933,194 - Yang , et al. January 13, 2 | 2015-01-13 |
Melanocortin Receptor-Specific Heptapeptides App 20140357575 - Shi; Yi-qun ;   et al. | 2014-12-04 |
Melanocortin-1 receptor-specific cyclic peptides Grant 8,877,890 - Yang , et al. November 4, 2 | 2014-11-04 |
Melanocortin receptor-specific peptides Grant 8,846,601 - Shi , et al. September 30, 2 | 2014-09-30 |
Melanocortin receptor-specific peptides for treatment of female sexual dysfunction Grant 8,729,224 - Shi , et al. May 20, 2 | 2014-05-20 |
Melanocortin-1 Receptor-Specific Cyclic Peptides App 20130296256 - Yang; Wei ;   et al. | 2013-11-07 |
Melanocortin Receptor-Specific Peptides for Treatment of Female Sexual Dysfunction App 20130288987 - Shi; Yi-Qun ;   et al. | 2013-10-31 |
Melanocortin Receptor-Specific Peptides App 20130237473 - Dodd; John H. ;   et al. | 2013-09-12 |
Melanocortin-1 receptor-specific cyclic peptides Grant 8,492,517 - Yang , et al. July 23, 2 | 2013-07-23 |
Melanocortin receptor-specific peptides for treatment of sexual dysfunction Grant 8,487,073 - Shi , et al. July 16, 2 | 2013-07-16 |
Melanocortin receptor-specific peptides Grant 8,455,617 - Dodd , et al. June 4, 2 | 2013-06-04 |
Melanocortin receptor-specific peptides Grant 8,455,618 - Dodd , et al. June 4, 2 | 2013-06-04 |
Melanocortin receptor-specific spiro-piperidine compounds Grant 8,263,608 - Shi , et al. September 11, 2 | 2012-09-11 |
Melanocortin-1 Receptor-Specific Linear Peptides App 20120225831 - Yang; Wei ;   et al. | 2012-09-06 |
Melanocortin-1 Receptor-Specific Cyclic Peptides App 20120225828 - Yang; Wei ;   et al. | 2012-09-06 |
N-alkylated cyclic peptide melanocortin agonists Grant 8,247,530 - Sharma , et al. August 21, 2 | 2012-08-21 |
Melanocortin Receptor-Specific Peptides App 20120178701 - Shi; Yi-qun ;   et al. | 2012-07-12 |
Melanocortin Receptor-specific Peptides App 20120046219 - DODD; John H. ;   et al. | 2012-02-23 |
Melanocortin Receptor-Specific Spiro-Piperidine Compounds App 20110178080 - Shi; Yi-Qun ;   et al. | 2011-07-21 |
Melanocortin receptor-specific piperazine compounds with diamine groups Grant 7,968,548 - Sharma , et al. June 28, 2 | 2011-06-28 |
Melanocortin receptor-specific compounds Grant 7,964,601 - Sharma , et al. June 21, 2 | 2011-06-21 |
Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction App 20110065652 - Shi; Yi-Qun ;   et al. | 2011-03-17 |
N-Alkylated Cyclic Peptide Melanocortin Agonists App 20110009341 - Sharma; Shubh D. ;   et al. | 2011-01-13 |
Melanocortin Receptor-specific Peptides App 20100311648 - DODD; John H. ;   et al. | 2010-12-09 |
Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents Grant 7,834,017 - Burris , et al. November 16, 2 | 2010-11-16 |
Peptidomimetics of biologically active metallopeptides Grant 7,807,678 - Sharma , et al. October 5, 2 | 2010-10-05 |
Substituted melanocortin receptor-specific single acyl piperazine compounds Grant 7,727,991 - Sharma , et al. June 1, 2 | 2010-06-01 |
Melanocortin receptor-specific piperazine and keto-piperazine compounds Grant 7,727,990 - Sharma , et al. June 1, 2 | 2010-06-01 |
Substituted melanocortin receptor-specific piperazine compounds Grant 7,718,802 - Sharma , et al. May 18, 2 | 2010-05-18 |
Substituted melanocortin receptor-specific piperazine compounds Grant 7,709,484 - Sharma , et al. May 4, 2 | 2010-05-04 |
Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669 App 20090305960 - Chen; Xin ;   et al. | 2009-12-10 |
Pyrrolidine melanocortin-specific compounds Grant 7,601,753 - Sharma , et al. October 13, 2 | 2009-10-13 |
Melanocortin receptor-specific compounds Grant 7,456,184 - Sharma , et al. November 25, 2 | 2008-11-25 |
Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds App 20080255033 - Sharma; Shubh D. ;   et al. | 2008-10-16 |
Melanocortin Receptor-Specific Compounds App 20080234289 - Sharma; Shubh D. ;   et al. | 2008-09-25 |
Method of making metallopeptides Grant 7,425,608 - Sharma , et al. September 16, 2 | 2008-09-16 |
Metallopeptide compounds Grant 7,385,025 - Sharma , et al. June 10, 2 | 2008-06-10 |
Piperazine melanocortin-specific compounds Grant 7,354,923 - Sharma , et al. April 8, 2 | 2008-04-08 |
Knockout identification of target-specific sites in peptides Grant 7,351,690 - Sharma , et al. April 1, 2 | 2008-04-01 |
Diamine-Containing, Tetra-Substituted Piperazine Compounds Having Identical 1- and 4-Substituents App 20080070921 - Burris; Kevin ;   et al. | 2008-03-20 |
Cyclic peptides for treatment of cachexia Grant 7,345,144 - Sharma , et al. March 18, 2 | 2008-03-18 |
Cyclic peptides for treatment for cachexia Grant 7,342,089 - Sharma , et al. March 11, 2 | 2008-03-11 |
Bicyclic melanocortin-specific compounds Grant 7,326,707 - Sharma , et al. February 5, 2 | 2008-02-05 |
Melanocortin metallopeptides for treatment of sexual dysfunction Grant 7,307,063 - Sharma , et al. December 11, 2 | 2007-12-11 |
Pyrrolidine Melanocortin-Specific Compounds App 20070155670 - Sharma; Shubh D. ;   et al. | 2007-07-05 |
Pyrrolidine melanocortin-specific compounds Grant 7,189,755 - Sharma , et al. March 13, 2 | 2007-03-13 |
Melanocortin Receptor-specific Piperazine Compounds With Diamine Groups App 20060287331 - SHARMA; Shubh D. ;   et al. | 2006-12-21 |
Melanocortin Receptor-Specific Piperazine and Keto-Piperazine Compounds App 20060287332 - SHARMA; Shubh D. ;   et al. | 2006-12-21 |
Substituted Melanocortin Receptor-Specific Single Acyl Piperazine Compounds App 20060287330 - SHARMA; Shubh D. ;   et al. | 2006-12-21 |
Cyclic peptides for treatment of cachexia App 20060014676 - Sharma; Shubh D. ;   et al. | 2006-01-19 |
Cyclic peptides for treatment of cachexia App 20060014194 - Sharma; Shubh D. ;   et al. | 2006-01-19 |
Metallopeptide compounds App 20050282739 - Sharma, Shubh D. ;   et al. | 2005-12-22 |
Substituted melanocortin receptor-specific piperazine compounds App 20050176728 - Sharma, Shubh D. ;   et al. | 2005-08-11 |
Naphthalene-containing melanocortin receptor-specific small molecule App 20050130988 - Sharma, Shubh D. ;   et al. | 2005-06-16 |
Identification of target-specific folding sites in peptides and proteins App 20050014193 - Sharma, Shubh D. ;   et al. | 2005-01-20 |
Knockout identification of target-specific sites in peptides App 20040248212 - Sharma, Shubh D. ;   et al. | 2004-12-09 |
Melanocortin receptor-specific compounds App 20040224957 - Sharma, Shubh D. ;   et al. | 2004-11-11 |
Peptidomimetics of biologically active metallopeptides App 20040171520 - Sharma, Shubh D. ;   et al. | 2004-09-02 |
Pyrrolidine melanocortin-specific compounds App 20040167201 - Sharma, Shubh D. ;   et al. | 2004-08-26 |
Piperazine melanocortin-specific compounds App 20040157264 - Sharma, Shubh D. ;   et al. | 2004-08-12 |
Bicyclic melanocortin-specific compounds App 20040152134 - Sharma, Shubh D. ;   et al. | 2004-08-05 |
Melanocortin metallopeptides for treatment of sexual dysfunction App 20040038897 - Sharma, Shubh D. ;   et al. | 2004-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.